XML 42 R25.htm IDEA: XBRL DOCUMENT v3.19.1
RESEARCH AND DEVELOPMENT ACTIVITY (Details 2) - Immune Ventures to INmune Bio ("Licensee"), ("PITT Agreement").
12 Months Ended
Dec. 31, 2018
USD ($)
Each Phase I initiation  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments $ 50,000
Each Phase III initiation  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments 500,000
First commercial sale of product making use of licensed technology  
Research and Development Arrangement, Contract to Perform for Others [Line Items]  
Payment method of milestone payments $ 1,250,000